Aoxin Q & M Dental Group Ltd
SGX:1D4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.8), the stock would be worth S$0.03 (86% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5.4 | S$0.19 |
0%
|
| 3-Year Average | 0.8 | S$0.03 |
-86%
|
| 5-Year Average | 2 | S$0.07 |
-64%
|
| Industry Average | 5.1 | S$0.18 |
-7%
|
| Country Average | 1.9 | S$0.07 |
-65%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| SG |
A
|
Aoxin Q & M Dental Group Ltd
SGX:1D4
|
198.5m SGD | 5.4 | 153.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 0.4 | 56 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 0.4 | 13.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0 | 12.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.5 | 23.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 1.4 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 2.4 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.9 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | 12.3 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 1.4 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.8 |
| Median | 1.9 |
| 70th Percentile | 4.4 |
| Max | 96 818.7 |
Other Multiples
Aoxin Q & M Dental Group Ltd
Glance View
Aoxin Q&M Dental Group Ltd. is an investment holding company, which engages in the provision of private dental services and dental equipment and supplies. The Company’s segments include Primary healthcare, Dental equipment and supplies distribution and Laboratory services. Primary healthcare comprising dentistry services. Distribution of dental equipment and supplies includes the distribution of equipment and supplies used in the provision of dental services. Laboratory services comprising the manufacturing of porcelain crown, bridges and dentures. The firm operates and manages approximately 11 dental centers, comprising four dental hospitals and seven polyclinics, in four different cities in Liaoning Province, including Shenyang, Huludao, Panjin and Gaizhou.
